Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Sep 4, 2026, 4:00 PM EDT
1.200
+0.020 (1.69%)
After-hours: Sep 4, 2026, 7:57 PM EDT
Marker Therapeutics Employees
Marker Therapeutics had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$709,334
Profits / Employee
-$1,741,476
Market Cap
19.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | -59 | -88.06% |
| Dec 31, 2022 | 67 | 11 | 19.64% |
| Dec 31, 2021 | 56 | 12 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Enlivex | 34 |
| Palatin Technologies | 29 |
| Cerenome | 28 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
| Lexaria Bioscience | 7 |
| Akari Therapeutics, | 6 |
MRKR News
- 22 days ago - Marker Therapeutics Quarterly report: Q2 2026 - Filings
- 3 months ago - Marker Therapeutics Quarterly report: Q1 2026 - Filings
- 5 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 5 months ago - Marker Therapeutics Proxy statement: Proxy filing - Filings
- 5 months ago - Marker Therapeutics reports FY25 EPS (79c), two estimates (94c) - TheFly
- 5 months ago - Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results - GlobeNewsWire
- 5 months ago - Marker Therapeutics Earnings release: Q4 2025 - Filings
- 5 months ago - Marker Therapeutics Annual report: Q4 2025 - Filings